Damora Therapeutics, Inc. (DMRA) vs MannKind Corporation (MNKD)
A side-by-side comparison of Damora Therapeutics, Inc. and MannKind Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DMRA
Damora Therapeutics, Inc.
$19.55HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
MNKD
MannKind Corporation
$3.71HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT
Total return — DMRA vs MNKD
growth of $100 · dividends reinvested · last 6yDMRA -94.6% (-38.5%/yr)MNKD +91.0% (+11.4%/yr)MNKD compounded faster over this window
Log scale — wide-divergence pair
DMRA MNKD
DMRA vs MNKD: by the numbers
- •DMRA is the larger company ($1.20B vs $1.18B market cap).
- •Both run net losses; DMRA's is the smaller (0.00% vs -11.08% net margin).
Metrics side by side
Valuation
| Metric | DMRA | MNKD |
|---|---|---|
| P/S ratio | N/A | 3.01 |
| P/B ratio | 3.12 | N/A |
| EV / EBITDA | N/A | 51.18 |
Profitability
| Metric | DMRA | MNKD |
|---|---|---|
| Gross margin | 0.00% | 75.69% |
| Operating margin | 0.00% | 11.12% |
| Net margin | 0.00% | -11.08% |
| ROE | -50.93% | N/A |
| ROIC | -52.44% | 1.32% |
Growth (annualized)
| Metric | DMRA | MNKD |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 39.51% |
| Total return CAGR (5Y) | -25.05% | -4.18% |
Frequently asked
- How have DMRA and MNKD total returns compared?
- Over the past 5 years, DMRA delivered -25.05% and MNKD delivered -4.18% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Damora Therapeutics ROEMannKind ROEDamora Therapeutics operating marginMannKind operating marginDamora Therapeutics revenue growthMannKind revenue growthDamora Therapeutics free cash flowMannKind free cash flow
Damora Therapeutics & MannKind appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.